Please login to the form below

Not currently logged in
Email:
Password:

Cancer Research UK's Karen Vousden to join BMS board

She will also serve on the pharma firm's Science and Technology Committee

Cancer Research UK's Karen Vousden is set to join Bristol-Myers Squibb’s board of directors in January.

Vousden is currently chief scientist at Cancer Research UK, as well as serving as group leader at the Francis Crick Institute in London, will also sit the pharma firm's Science and Technology Committee.

She has more than 30 years experience in cancer research and her previous roles have included director of the Beatson Institute for Cancer Research and leadership positions at the US National Cancer Institute.

Giovanni Caforio, BMS’ chairman and chief executive officer, said: "Karen is a world class cancer researcher and a highly accomplished leader in her field.

“Her understanding of cancer biology and immunology research will bring valuable insights to advancing our strategy and strong pipeline in oncology along with our broader pipeline of transformational medicines.”

18th September 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

blood
‘How is your day?’
The initiative that shows how plasma protein therapies improve lives...
women
Advancing women in healthcare
Fostering the next generation of leaders...
The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....

Infographics